The global market for Medicated Confectionery was valued at US$ 8647 million in the year 2024 and is projected to reach a revised size of US$ 10340 million by 2031, growing at a CAGR of 2.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medicated Confectionery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicated Confectionery.
The Medicated Confectionery market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicated Confectionery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicated Confectionery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Nestle
Perfetti Van Melle
Wm. Wrigley Jr. Company
Mondelez International
Reckitt Benckiser
Ricola
Procter & Gamble
Hershey's
Meda Pharmaceuticals
Ernest Jackson
Pedimont Candy Company
UHA Mikakuto
Universal Robina
Jakemans
Herbion International
HEXOS
Segment by Type
Hard Boiled Candies or Lozenges
Medicated Gums and Chewing Gums
Other
Segment by Application
Hospital
Medicine Retail
Health Products Store
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicated Confectionery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicated Confectionery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Medicated Confectionery Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 Medicated Confectionery by Type
1.2.1 Global Medicated Confectionery Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 Hard Boiled Candies or Lozenges
1.2.3 Medicated Gums and Chewing Gums
1.2.4 Other
1.3 Medicated Confectionery by Application
1.3.1 Global Medicated Confectionery Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Medicine Retail
1.3.4 Health Products Store
1.4 Global Medicated Confectionery Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Medicated Confectionery Revenue 2020-2031
1.4.2 Global Medicated Confectionery Sales 2020-2031
1.4.3 Global Medicated Confectionery Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medicated Confectionery Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Medicated Confectionery Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global Medicated Confectionery Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global Medicated Confectionery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medicated Confectionery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medicated Confectionery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicated Confectionery, Product Type & Application
2.7 Global Key Manufacturers of Medicated Confectionery, Date of Enter into This Industry
2.8 Global Medicated Confectionery Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global Medicated Confectionery Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest Medicated Confectionery Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global Medicated Confectionery Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medicated Confectionery Âé¶¹Ô´´ Scenario by Region
3.1 Global Medicated Confectionery Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medicated Confectionery Sales by Region: 2020-2031
3.2.1 Global Medicated Confectionery Sales by Region: 2020-2025
3.2.2 Global Medicated Confectionery Sales by Region: 2026-2031
3.3 Global Medicated Confectionery Revenue by Region: 2020-2031
3.3.1 Global Medicated Confectionery Revenue by Region: 2020-2025
3.3.2 Global Medicated Confectionery Revenue by Region: 2026-2031
3.4 North America Medicated Confectionery Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Medicated Confectionery Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medicated Confectionery Sales by Country (2020-2031)
3.4.3 North America Medicated Confectionery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicated Confectionery Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Medicated Confectionery Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medicated Confectionery Sales by Country (2020-2031)
3.5.3 Europe Medicated Confectionery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicated Confectionery Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific Medicated Confectionery Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medicated Confectionery Sales by Region (2020-2031)
3.6.3 Asia Pacific Medicated Confectionery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicated Confectionery Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Medicated Confectionery Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medicated Confectionery Sales by Country (2020-2031)
3.7.3 Latin America Medicated Confectionery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicated Confectionery Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Medicated Confectionery Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medicated Confectionery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medicated Confectionery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medicated Confectionery Sales by Type (2020-2031)
4.1.1 Global Medicated Confectionery Sales by Type (2020-2025)
4.1.2 Global Medicated Confectionery Sales by Type (2026-2031)
4.1.3 Global Medicated Confectionery Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global Medicated Confectionery Revenue by Type (2020-2031)
4.2.1 Global Medicated Confectionery Revenue by Type (2020-2025)
4.2.2 Global Medicated Confectionery Revenue by Type (2026-2031)
4.2.3 Global Medicated Confectionery Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global Medicated Confectionery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medicated Confectionery Sales by Application (2020-2031)
5.1.1 Global Medicated Confectionery Sales by Application (2020-2025)
5.1.2 Global Medicated Confectionery Sales by Application (2026-2031)
5.1.3 Global Medicated Confectionery Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global Medicated Confectionery Revenue by Application (2020-2031)
5.2.1 Global Medicated Confectionery Revenue by Application (2020-2025)
5.2.2 Global Medicated Confectionery Revenue by Application (2026-2031)
5.2.3 Global Medicated Confectionery Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global Medicated Confectionery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Nestle
6.1.1 Nestle Company Information
6.1.2 Nestle Description and Business Overview
6.1.3 Nestle Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Nestle Medicated Confectionery Product Portfolio
6.1.5 Nestle Recent Developments/Updates
6.2 Perfetti Van Melle
6.2.1 Perfetti Van Melle Company Information
6.2.2 Perfetti Van Melle Description and Business Overview
6.2.3 Perfetti Van Melle Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Perfetti Van Melle Medicated Confectionery Product Portfolio
6.2.5 Perfetti Van Melle Recent Developments/Updates
6.3 Wm. Wrigley Jr. Company
6.3.1 Wm. Wrigley Jr. Company Company Information
6.3.2 Wm. Wrigley Jr. Company Description and Business Overview
6.3.3 Wm. Wrigley Jr. Company Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wm. Wrigley Jr. Company Medicated Confectionery Product Portfolio
6.3.5 Wm. Wrigley Jr. Company Recent Developments/Updates
6.4 Mondelez International
6.4.1 Mondelez International Company Information
6.4.2 Mondelez International Description and Business Overview
6.4.3 Mondelez International Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mondelez International Medicated Confectionery Product Portfolio
6.4.5 Mondelez International Recent Developments/Updates
6.5 Reckitt Benckiser
6.5.1 Reckitt Benckiser Company Information
6.5.2 Reckitt Benckiser Description and Business Overview
6.5.3 Reckitt Benckiser Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Reckitt Benckiser Medicated Confectionery Product Portfolio
6.5.5 Reckitt Benckiser Recent Developments/Updates
6.6 Ricola
6.6.1 Ricola Company Information
6.6.2 Ricola Description and Business Overview
6.6.3 Ricola Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ricola Medicated Confectionery Product Portfolio
6.6.5 Ricola Recent Developments/Updates
6.7 Procter & Gamble
6.7.1 Procter & Gamble Company Information
6.7.2 Procter & Gamble Description and Business Overview
6.7.3 Procter & Gamble Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Procter & Gamble Medicated Confectionery Product Portfolio
6.7.5 Procter & Gamble Recent Developments/Updates
6.8 Hershey's
6.8.1 Hershey's Company Information
6.8.2 Hershey's Description and Business Overview
6.8.3 Hershey's Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hershey's Medicated Confectionery Product Portfolio
6.8.5 Hershey's Recent Developments/Updates
6.9 Meda Pharmaceuticals
6.9.1 Meda Pharmaceuticals Company Information
6.9.2 Meda Pharmaceuticals Description and Business Overview
6.9.3 Meda Pharmaceuticals Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Meda Pharmaceuticals Medicated Confectionery Product Portfolio
6.9.5 Meda Pharmaceuticals Recent Developments/Updates
6.10 Ernest Jackson
6.10.1 Ernest Jackson Company Information
6.10.2 Ernest Jackson Description and Business Overview
6.10.3 Ernest Jackson Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ernest Jackson Medicated Confectionery Product Portfolio
6.10.5 Ernest Jackson Recent Developments/Updates
6.11 Pedimont Candy Company
6.11.1 Pedimont Candy Company Company Information
6.11.2 Pedimont Candy Company Description and Business Overview
6.11.3 Pedimont Candy Company Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pedimont Candy Company Medicated Confectionery Product Portfolio
6.11.5 Pedimont Candy Company Recent Developments/Updates
6.12 UHA Mikakuto
6.12.1 UHA Mikakuto Company Information
6.12.2 UHA Mikakuto Description and Business Overview
6.12.3 UHA Mikakuto Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 UHA Mikakuto Medicated Confectionery Product Portfolio
6.12.5 UHA Mikakuto Recent Developments/Updates
6.13 Universal Robina
6.13.1 Universal Robina Company Information
6.13.2 Universal Robina Description and Business Overview
6.13.3 Universal Robina Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Universal Robina Medicated Confectionery Product Portfolio
6.13.5 Universal Robina Recent Developments/Updates
6.14 Jakemans
6.14.1 Jakemans Company Information
6.14.2 Jakemans Description and Business Overview
6.14.3 Jakemans Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jakemans Medicated Confectionery Product Portfolio
6.14.5 Jakemans Recent Developments/Updates
6.15 Herbion International
6.15.1 Herbion International Company Information
6.15.2 Herbion International Description and Business Overview
6.15.3 Herbion International Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Herbion International Medicated Confectionery Product Portfolio
6.15.5 Herbion International Recent Developments/Updates
6.16 HEXOS
6.16.1 HEXOS Company Information
6.16.2 HEXOS Description and Business Overview
6.16.3 HEXOS Medicated Confectionery Sales, Revenue and Gross Margin (2020-2025)
6.16.4 HEXOS Medicated Confectionery Product Portfolio
6.16.5 HEXOS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicated Confectionery Industry Chain Analysis
7.2 Medicated Confectionery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicated Confectionery Production Mode & Process Analysis
7.4 Medicated Confectionery Sales and Âé¶¹Ô´´ing
7.4.1 Medicated Confectionery Sales Channels
7.4.2 Medicated Confectionery Distributors
7.5 Medicated Confectionery Customer Analysis
8 Medicated Confectionery Âé¶¹Ô´´ Dynamics
8.1 Medicated Confectionery Industry Trends
8.2 Medicated Confectionery Âé¶¹Ô´´ Drivers
8.3 Medicated Confectionery Âé¶¹Ô´´ Challenges
8.4 Medicated Confectionery Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Nestle
Perfetti Van Melle
Wm. Wrigley Jr. Company
Mondelez International
Reckitt Benckiser
Ricola
Procter & Gamble
Hershey's
Meda Pharmaceuticals
Ernest Jackson
Pedimont Candy Company
UHA Mikakuto
Universal Robina
Jakemans
Herbion International
HEXOS
Ìý
Ìý
*If Applicable.